introduce immune response patient novel ahn virus infect van incomplete character investing profil th media interferoninduc protein ip group sever mild disease correct clinic aspect method thirtytwo host confirm enroll studi nvahnacut respiratory distress syndrome ard one group bacteria sepsisard not health volume ad compare cytokine level tandem influenza nvahnard serum sample obtain admins day later record prospect result ones lymphocytopenia common interleukin il tumor necrosis factor tnÎ± significantly increase versus control compare higher nonsurvivor survivor remain post correct creative day inter symptom onset neg profit ratio found ones signifies level viral concur critic ill hallmark sever cytokine except delay differ 